Radiology Business November 8, 2023
The Centers for Medicare & Medicaid Services recently released its final Hospital Outpatient Prospective Payment System rule, which does not include changes to reimbursement bundling for diagnostic radiopharmaceuticals.
CMS previously issued the initial proposed rule in July, soliciting feedback from the field on potentially granting a separate payment for such contrast agents, rather than lumping them together with the exam. Industry advocates have long fought for this change, noting that the current bundling system creates a barrier for those who need expensive newer contrast agents.
The agency said Nov. 2 that it received “considerable interest” in the comment solicitation, with respondents providing “various insights and potential policy changes.” CMS emphasized it still thinks that diagnostic radiopharmaceuticals should be packaged into...
Today's Sponsors
Today's Sponsor